CETUXIMAB AND RADIOTHERAPY IN H&N?

被引：0
|
作者：
Budach, W. [1 ]
Matuschek, C. [1 ]
Bolke, E. [1 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Radiat Oncol, Dusseldorf, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2012年 / 104卷
关键词：
D O I：
10.1016/S0167-8140(15)34590-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-36
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [31] MRI-based adaptive radiotherapy has the potential to reduce dysphagia in H&N cancer patients
    Grepl, Jakub
    Sirak, Igor
    Vosmik, Milan
    Pohankova, Denisa
    Hodek, Miroslav
    Paluska, Petr
    Tichy, Ales
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1313 - S1319
  • [32] RAPIDARC COMPARED TO IMRT FOR H&N CANCER
    de Palma, E. Vanetti
    Clivio, A.
    Nicolini, G.
    Cozzi, A. Fogliata
    Ghosh-Laskar, S.
    Agarwal, J. P.
    Upreti, R. R.
    Budrukkar, A.
    Murthy, V.
    Deshpande, D.
    Shrivastava, S. K.
    Dinshaw, K.
    Cozzi, L.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S48 - S49
  • [33] Dosimetric evaluation of deep learning generated synthetic CT data for H&N MRI only radiotherapy
    Palmer, E.
    Karlsson, A.
    Nordstrom, F.
    Siversson, C.
    Petruson, K.
    Ljungberg, M.
    Sohlin, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S963 - S964
  • [34] A new paradigm for brachytherapy in H&N oncology
    Peiffert, D.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S122 - S122
  • [35] Results of an international phase III trial of radiation ± Cetuximab (Erbitux™) in patients with locoregionally advanced head & neck (H&N) cancer
    Harari, Paul M.
    Giralt, Jordi L.
    Chinnaiyan, Prakash
    Azarnia, Nosar
    Molloy, Patricia
    Cohen, Roger
    Raben, David
    Jones, Christopher
    Kies, Merrill S.
    Baselga, Jose
    Ang, Kian K.
    Bonner, James A.
    ANNALS OF ONCOLOGY, 2004, 15 : 13 - 13
  • [36] Concomitant boost radiotherapy as a routine treatement for H&N cancers: A 10-year single institution experience
    Allal, AS
    Taussky, D
    Mach, N
    Becker, M
    Bieri, S
    Dulguerov, P
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 96 - 96
  • [37] Data-Driven Generation of CBCT-To-CT HU Mapping for Adaptive Radiotherapy in H&N Cancer
    Wang, H.
    Rea, A.
    Xue, J.
    Spuhler, K.
    Qu, T.
    Chen, T.
    Barbee, D.
    Hu, K.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [38] Daily on board CT in course of H&N radiotherapy. Comparison of manual and automatically propagated parotid contours
    Spiazzi, L.
    Buglione, M.
    Tonoli, S.
    Avitabile, R.
    Bandera, A.
    Triggiani, L.
    Cavagnini, R.
    Magrini, S. M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S248 - S248
  • [39] Fitting NTCP models to patient reported xerostomia and dysphagia after H&N radiotherapy to 60Gy
    Mavroidis, P.
    Price, A.
    Fried, D.
    Kostich, M.
    Amdur, R.
    Mendenhall, W.
    Lu, C.
    Das, S.
    Marks, L. B.
    Chera, B.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S269 - S270
  • [40] SPECT/CT, SLNs, and H&N Cutaneous Cancers
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01) : 18N - 18N
12345